Uhi Toh

1.5k total citations
79 papers, 1.1k citations indexed

About

Uhi Toh is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Uhi Toh has authored 79 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 20 papers in Immunology and 19 papers in Surgery. Recurrent topics in Uhi Toh's work include Immunotherapy and Immune Responses (18 papers), Cancer Immunotherapy and Biomarkers (18 papers) and Breast Cancer Treatment Studies (14 papers). Uhi Toh is often cited by papers focused on Immunotherapy and Immune Responses (18 papers), Cancer Immunotherapy and Biomarkers (18 papers) and Breast Cancer Treatment Studies (14 papers). Uhi Toh collaborates with scholars based in Japan, United States and United Kingdom. Uhi Toh's co-authors include Kazuo Shirouzu, Teruhiko Fujii, Hideaki Yamana, Nobutaka Iwakuma, Hiromasa Fujita, Yoshito Akagi, Masayoshi Kage, Susumu Sueyoshi, Naoko Seki and Takashi Mine and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of the New York Academy of Sciences.

In The Last Decade

Uhi Toh

76 papers receiving 1.1k citations

Peers

Uhi Toh
Noriaki Tezuka Japan
Jashodeep Datta United States
Jun Jia China
Yang Qu China
Shreyas Joshi United States
Changsong Qi China
Taigo Kato Japan
Rosa Tambaro Italy
Lionel D’Hondt Belgium
Noriaki Tezuka Japan
Uhi Toh
Citations per year, relative to Uhi Toh Uhi Toh (= 1×) peers Noriaki Tezuka

Countries citing papers authored by Uhi Toh

Since Specialization
Citations

This map shows the geographic impact of Uhi Toh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uhi Toh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uhi Toh more than expected).

Fields of papers citing papers by Uhi Toh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uhi Toh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uhi Toh. The network helps show where Uhi Toh may publish in the future.

Co-authorship network of co-authors of Uhi Toh

This figure shows the co-authorship network connecting the top 25 collaborators of Uhi Toh. A scholar is included among the top collaborators of Uhi Toh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uhi Toh. Uhi Toh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Watanabe, Hidetaka, et al.. (2023). Multi-tracer sentinel node biopsy for patients with breast cancer after neoadjuvant chemotherapy. Medical Research Archives. 11(12).
3.
Shibata, Tatsuhiro, Nagisa Morikawa, Shinichiro ITO, et al.. (2023). Cardiovascular adverse events and prognosis in patients with haematologic malignancies and breast cancer receiving anticancer agents: Kurume-CREO Registry insights. European Journal of Preventive Cardiology. 30(18). 1941–1949. 8 indexed citations
4.
5.
6.
Toh, Uhi, et al.. (2022). Efficacy and Safety of Monthly Minodronate Therapy in Postmenopausal Breast Cancer Patients Receiving Aromatase Inhibitors. Anticancer Research. 42(8). 4139–4143. 1 indexed citations
7.
Sakamoto, Shinjiro, Satoko Matsueda, Shinzo Takamori, et al.. (2017). Immunological evaluation of peptide vaccination for cancer patients with the HLA ‐A11+ or ‐A33+ allele. Cancer Science. 108(4). 598–603. 4 indexed citations
8.
Shibata, Tomohiro, Kosuke Watari, Hiroto Izumi, et al.. (2016). Breast Cancer Resistance to Antiestrogens Is Enhanced by Increased ER Degradation and ERBB2 Expression. Cancer Research. 77(2). 545–556. 27 indexed citations
9.
Toh, Uhi, et al.. (2015). Navigation surgery for intraoperative sentinel lymph node detection using Indocyanine green (ICG) fluorescence real-time imaging in breast cancer. Breast Cancer Research and Treatment. 153(2). 337–344. 42 indexed citations
10.
Toh, Uhi, Nobutaka Iwakuma, Shino Nakagawa, et al.. (2014). Primary breast peripheral T-cell lymphoma not otherwise specified: report of a case. Surgery Today. 45(1). 115–120. 3 indexed citations
11.
Toh, Uhi, et al.. (2014). Evaluation of contrast Sonazoid-enhanced ultrasonography for the detection of hepatic metastases in breast cancer. Breast Cancer. 23(2). 231–241. 23 indexed citations
12.
Fujii, Teruhiko, Uhi Toh, Nobutaka Iwakuma, et al.. (2013). Phase II clinical trial of metronomic chemotherapy with combined irinotecan and tegafur–gimeracil–oteracil potassium in metastatic and recurrent breast cancer. Breast Cancer. 22(4). 335–342. 17 indexed citations
13.
Takenaka, Miki, Uhi Toh, Hiroki Takahashi, et al.. (2011). Giant Malignant Phyllodes Tumor: A Case Report. The Kurume Medical Journal. 58(2). 67–72. 5 indexed citations
14.
Yamaguchi, Rin, Maki Tanaka, Toshiro Yokoyama, et al.. (2009). Clinicocytopathology of breast cancers with a ring‐like appearance on ultrasonography and/or magnetic resonance imaging. Pathology International. 60(1). 22–26. 4 indexed citations
15.
Fujita, Hiromasa, Susumu Sueyoshi, Toshiaki Tanaka, et al.. (2003). Adjuvant Chemotherapy after Radical Resection of Squamous Cell Carcinoma in the Thoracic Esophagus: Who Benefits?. Digestive Surgery. 20(3). 229–237. 19 indexed citations
16.
Toh, Uhi, Tomoya Sudo, Hisako Sasahara, et al.. (2002). Locoregional adoptive immunotherapy resulted in regression in distant metastases of a recurrent esophageal cancer. International Journal of Clinical Oncology. 7(6). 372–375. 11 indexed citations
17.
Inoue, Yoshiko, Masanobu Nakao, Kazuko Matsunaga, et al.. (2000). Induction of Human Leukocyte Antigen-A26–Restricted and Tumor-Specific Cytotoxic T Lymphocytes by a Single Peptide of the SART1 Antigen in Patients With Cancer With Different A26 Subtypes. Journal of Immunotherapy. 23(3). 296–303. 4 indexed citations
18.
Fujii, Teruhiko, Hideaki Yamana, Susumu Sueyoshi, et al.. (2000). Histopathological analysis of non-malignant and malignant epithelium in achalasia of the esophagus. Diseases of the Esophagus. 13(2). 110–116. 12 indexed citations
19.
Fujii, Teruhiko, et al.. (1997). The effect of radioimmunotherapy using murine monoclonal antibody KIS1 on esophageal squamous cell carcinoma-bearing nude mice. Surgery Today. 27(11). 1026–1034. 2 indexed citations
20.
Toh, Uhi, Hideaki Yamana, Hiromasa Fujita, et al.. (1996). A monoclonal antibody KIS-1 recognizing a new membrane antigen on human squamous-cell carcinoma. International Journal of Cancer. 66(5). 600–606. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noriaki Tezuka Breakdown of academic impact, for papers by Jashodeep Datta Breakdown of academic impact, for papers by Jun Jia Breakdown of academic impact, for papers by Yang Qu Breakdown of academic impact, for papers by Shreyas Joshi Breakdown of academic impact, for papers by Changsong Qi Breakdown of academic impact, for papers by Taigo Kato Breakdown of academic impact, for papers by Rosa Tambaro Breakdown of academic impact, for papers by Lionel D’Hondt
Rankless by CCL
2026